Pias1 is essential for erythroid and vascular development in the mouse embryo

Developmental Biology

Volumn 415, Issue 1, 2016, Pages 98-110

  Constanzo, Jerfiz D ^a   Deng, Mi ^a   Rindhe, Smita ^a   Tang, Ke jing ^a,b   Zhang, Cheng cheng ^a   Scaglioni, Pier Paolo ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Angiogenesis; Embryonic development; Fetal erythropoiesis; Pias1; Yolk sac capillary plexus

Indexed keywords

CASPASE 3; MYOD PROTEIN; MYOGENIN; TRANSCRIPTION FACTOR GATA 4; PIAS1 PROTEIN, MOUSE; PROTEIN INHIBITOR OF ACTIVATED STAT; TRANSCRIPTION FACTOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL LOSS; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; ERYTHROCYTE; ERYTHROPOIESIS; GATA 4 GENE; GENE; GENE ACTIVATION; GENE DISRUPTION; GENE EXPRESSION; GENE LOSS; MOUSE; MUSCLE MASS; MYOD GENE; MYOGENIN GENE; MYOMAKER GENE; NONHUMAN; PIAS1 GENE; PRIORITY JOURNAL; RNA INTERFERENCE; STOP CODON; UPREGULATION; ANIMAL; CELL CULTURE; CYTOLOGY; DEFICIENCY; EMBRYOLOGY; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; GERM LAYER; GROWTH, DEVELOPMENT AND AGING; HEART; INTRAUTERINE GROWTH RETARDATION; LETHAL GENE; MACROPHAGE; MYELOPOIESIS; PATHOLOGY; PENETRANCE; PHYSIOLOGY; SUMOYLATION; VASCULARIZATION; YOLK SAC;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; EMBRYONIC DEVELOPMENT; ENDOTHELIAL CELLS; ERYTHROPOIESIS; FETAL GROWTH RETARDATION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENES, LETHAL; GERM LAYERS; HEART; MACROPHAGES; MICE; MYELOPOIESIS; NEOVASCULARIZATION, PHYSIOLOGIC; PENETRANCE; PROTEIN INHIBITORS OF ACTIVATED STAT; SUMOYLATION; TRANSCRIPTION FACTORS; YOLK SAC;

EID: 84969549231     PISSN: 00121606     EISSN: 1095564X     Source Type: Journal    
DOI: 10.1016/j.ydbio.2016.04.013     Document Type: Article

References (50)

1. Auerbach R., Huang H., Lu L. Hematopoietic stem cells in the mouse embryonic yolk sac. Stem Cells 1996, 14:269-280.
2. Baudino T.A., McKay C., Pendeville-Samain H., Nilsson J.A., Maclean K.H., White E.L., Davis A.C., Ihle J.N., Cleveland J.L. c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression. Genes Dev. 2002, 16:2530-2543.
3. Beliakoff J., Lee J., Ueno H., Aiyer A., Weissman I.L., Barsh G.S., Cardiff R.D., Sun Z. The PIAS-like protein Zimp10 is essential for embryonic viability and proper vascular development. Mol. Cell. Biol. 2008, 28:282-292.
4. Berkes C.A., Tapscott S.J. MyoD and the transcriptional control of myogenesis. Semin. Cell Dev. Biol. 2005, 16:585-595.
5. Bernardi R., Pandolfi P.P. Role of PML and the PML-nuclear body in the control of programmed cell death. Oncogene 2003, 22:9048-9057.
6. Coffin J.D., Poole T.J. Endothelial cell origin and migration in embryonic heart and cranial blood vessel development. Anat. Rec. 1991, 231:383-395.
7. Coffin J.D., Harrison J., Schwartz S., Heimark R. Angioblast differentiation and morphogenesis of the vascular endothelium in the mouse embryo. Dev. Biol. 1991, 148:51-62.
8. Collavin L., Gostissa M., Avolio F., Secco P., Ronchi A., Santoro C., Del Sal G. Modification of the erythroid transcription factor GATA-1 by SUMO-1. Proc. Natl. Acad. Sci. USA 2004, 101:8870-8875.
9. Conway S.J., Kruzynska-Frejtag A., Kneer P.L., Machnicki M., Koushik S.V. What cardiovascular defect does my prenatal mouse mutant have, and why?. Genesis 2003, 35:1-21.
10. Costa M.W., Lee S., Furtado M.B., Xin L., Sparrow D.B., Martinez C.G., Dunwoodie S.L., Kurtenbach E., Mohun T., Rosenthal N., et al. Complex SUMO-1 regulation of cardiac transcription factor Nkx2-5. PLoS One 2011, 6:e24812.
11. Dbouk H.A., Weil L.M., Perera G.K., Dellinger M.T., Pearson G., Brekken R.A., Cobb M.H. Actions of the protein kinase WNK1 on endothelial cells are differentially mediated by its substrate kinases OSR1 and SPAK. Proc. Natl. Acad. Sci. USA 2014, 111:15999-16004.
12. Dellinger M.T., Meadows S.M., Wynne K., Cleaver O., Brekken R.A. Vascular endothelial growth factor receptor-2 promotes the development of the lymphatic vasculature. PLoS One 2013, 8:e74686.
13. Dunworth W.P., Cardona-Costa J., Bozkulak E.C., Kim J.D., Meadows S., Fischer J.C., Wang Y., Cleaver O., Qyang Y., Ober E.A., et al. Bone morphogenetic protein 2 signaling negatively modulates lymphatic development in vertebrate embryos. Circ. Res. 2014, 114:56-66.
14. Feng N., Wang Z., Zhang Z., He X., Wang C., Zhang L. miR-487b promotes human umbilical vein endothelial cell proliferation, migration, invasion and tube formation through regulating THBS1. Neurosci. Lett. 2015, 591:1-7.
15. Galanty Y., Belotserkovskaya R., Coates J., Polo S., Miller K.M., Jackson S.P. Mammalian SUMO E3-ligases PIAS1 and PIAS4 promote responses to DNA double-strand breaks. Nature 2009, 462:935-939.
16. Giorgi C., Ito K., Lin H.K., Santangelo C., Wieckowski M.R., Lebiedzinska M., Bononi A., Bonora M., Duszynski J., Bernardi R., et al. PML regulates apoptosis at endoplasmic reticulum by modulating calcium release. Science 2010, 330:1247-1251.
17. Gomez Perdiguero E., Klapproth K., Schulz C., Busch K., Azzoni E., Crozet L., Garner H., Trouillet C., de Bruijn M.F., Geissmann F., et al. Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors. Nature 2015, 518:547-551.
18. Ip H.S., Wilson D.B., Heikinheimo M., Tang Z., Ting C.N., Simon M.C., Leiden J.M., Parmacek M.S. The GATA-4 transcription factor transactivates the cardiac muscle-specific troponin C promoter-enhancer in nonmuscle cells. Mol. Cell. Biol. 1994, 14:7517-7526.
19. Jacobsen R.N., Forristal C.E., Raggatt L.J., Nowlan B., Barbier V., Kaur S., van Rooijen N., Winkler I.G., Pettit A.R., Levesque J.P. Mobilization with granulocyte colony-stimulating factor blocks medullar erythropoiesis by depleting F4/80(+)VCAM1(+)CD169(+)ER-HR3(+)Ly6G(+) erythroid island macrophages in the mouse. Exp. Hematol. 2014, 42. 547-561 e544.
20. Kalamarz M.E., Paddibhatla I., Nadar C., Govind S. Sumoylation is tumor-suppressive and confers proliferative quiescence to hematopoietic progenitors in Drosophila melanogaster larvae. Biol. Open 2012, 1:161-172.
21. Kelley C., Blumberg H., Zon L.I., Evans T. GATA-4 is a novel transcription factor expressed in endocardium of the developing heart. Development 1993, 118:817-827.
22. Koni P.A., Joshi S.K., Temann U.A., Olson D., Burkly L., Flavell R.A. Conditional vascular cell adhesion molecule 1 deletion in mice: impaired lymphocyte migration to bone marrow. J. Exp. Med. 2001, 193:741-754.
23. Lacaud G., Robertson S., Palis J., Kennedy M., Keller G. Regulation of hemangioblast development. Ann. N. Y. Acad. Sci. 2001, 938:96-107. discussion 108.
24. Lee H.Y., Johnson K.D., Fujiwara T., Boyer M.E., Kim S.I., Bresnick E.H. Controlling hematopoiesis through sumoylation-dependent regulation of a GATA factor. Mol. Cell 2009, 36:984-995.
25. Liu B., Yee K.M., Tahk S., Mackie R., Hsu C., Shuai K. PIAS1 SUMO ligase regulates the self-renewal and differentiation of hematopoietic stem cells. EMBO J. 2014, 33:101-113.
26. Liu B., Mink S., Wong K.A., Stein N., Getman C., Dempsey P.W., Wu H., Shuai K. PIAS1 selectively inhibits interferon-inducible genes and is important in innate immunity. Nat. Immunol. 2004, 5:891-898.
27. Liu B., Tahk S., Yee K.M., Yang R., Yang Y., Mackie R., Hsu C., Chernishof V., O'Brien N., Jin Y., et al. PIAS1 regulates breast tumorigenesis through selective epigenetic gene silencing. PLoS One 2014, 9:e89464.
28. Lucitti J.L., Jones E.A., Huang C., Chen J., Fraser S.E., Dickinson M.E. Vascular remodeling of the mouse yolk sac requires hemodynamic force. Development 2007, 134:3317-3326.
29. Maeda T., Ito K., Merghoub T., Poliseno L., Hobbs R.M., Wang G., Dong L., Maeda M., Dore L.C., Zelent A., et al. LRF is an essential downstream target of GATA1 in erythroid development and regulates BIM-dependent apoptosis. Dev. Cell 2009, 17:527-540.
30. McKenna C.C., Ojeda A.F., Spurlin J., Kwiatkowski S., Lwigale P.Y. Sema3A maintains corneal avascularity during development by inhibiting Vegf induced angioblast migration. Dev. Biol. 2014, 391:241-250.
31. Meadows S.M., Ratliff L.A., Singh M.K., Epstein J.A., Cleaver O. Resolution of defective dorsal aortae patterning in Sema3E-deficient mice occurs via angiogenic remodeling. Dev. Dyn. 2013, 242:580-590.
32. Millay D.P., O'Rourke J.R., Sutherland L.B., Bezprozvannaya S., Shelton J.M., Bassel-Duby R., Olson E.N. Myomaker is a membrane activator of myoblast fusion and muscle formation. Nature 2013, 499:301-305.
33. Myers C.T., Krieg P.A. BMP-mediated specification of the erythroid lineage suppresses endothelial development in blood island precursors. Blood 2013, 122:3929-3939.
34. Nacerddine K., Lehembre F., Bhaumik M., Artus J., Cohen-Tannoudji M., Babinet C., Pandolfi P.P., Dejean A. The SUMO pathway is essential for nuclear integrity and chromosome segregation in mice. Dev. Cell 2005, 9:769-779.
35. Olson E.N., Brennan T.J., Chakraborty T., Cheng T.C., Cserjesi P., Edmondson D., James G., Li L. Molecular control of myogenesis: antagonism between growth and differentiation. Mol. Cell. Biochem. 1991, 104:7-13.
36. Palvimo J.J. PIAS proteins as regulators of small ubiquitin-related modifier (SUMO) modifications and transcription. Biochem. Soc. Trans. 2007, 35:1405-1408.
37. Pang C.J., Lemsaddek W., Alhashem Y.N., Bondzi C., Redmond L.C., Ah-Son N., Dumur C.I., Archer K.J., Haar J.L., Lloyd J.A., et al. Kruppel-like factor 1 (KLF1), KLF2, and Myc control a regulatory network essential for embryonic erythropoiesis. Mol. Cell. Biol. 2012, 32:2628-2644.
38. Rabellino A., Carter B., Konstantinidou G., Wu S.Y., Rimessi A., Byers L.A., Heymach J.V., Girard L., Chiang C.M., Teruya-Feldstein J., et al. The SUMO E3-ligase PIAS1 regulates the tumor suppressor PML and its oncogenic counterpart PML-RARA. Cancer Res. 2012, 72:2275-2284.
39. Rytinki M.M., Kaikkonen S., Pehkonen P., Jaaskelainen T., Palvimo J.J. PIAS proteins: pleiotropic interactors associated with SUMO. Cell. Mol. Life Sci. 2009, 66:3029-3041.
40. Shalaby F., Rossant J., Yamaguchi T.P., Gertsenstein M., Wu X.F., Breitman M.L., Schuh A.C. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 1995, 376:62-66.
41. Stefater J.A., Lewkowich I., Rao S., Mariggi G., Carpenter A.C., Burr A.R., Fan J., Ajima R., Molkentin J.D., Williams B.O., et al. Regulation of angiogenesis by a non-canonical Wnt-Flt1 pathway in myeloid cells. Nature 2011, 474:511-515.
42. Sturgeon C.M., Ditadi A., Awong G., Kennedy M., Keller G. Wnt signaling controls the specification of definitive and primitive hematopoiesis from human pluripotent stem cells. Nat. Biotechnol. 2014, 32:554-561.
43. Sturgeon C.M., Chicha L., Ditadi A., Zhou Q., McGrath K.E., Palis J., Hammond S.M., Wang S., Olson E.N., Keller G. Primitive erythropoiesis is regulated by miR-126 via nonhematopoietic Vcam-1+ cells. Dev. Cell 2012, 23:45-57.
44. Tamplin O.J., Durand E.M., Carr L.A., Childs S.J., Hagedorn E.J., Li P., Yzaguirre A.D., Speck N.A., Zon L.I. Hematopoietic stem cell arrival triggers dynamic remodeling of the perivascular niche. Cell 2015, 160:241-252.
45. Tang Y., Harrington A., Yang X., Friesel R.E., Liaw L. The contribution of the Tie2+ lineage to primitive and definitive hematopoietic cells. Genesis 2010, 48:563-567.
46. Ueno H., Weissman I.L. Clonal analysis of mouse development reveals a polyclonal origin for yolk sac blood islands. Dev. Cell 2006, 11:519-533.
47. Wang J., Feng X.H., Schwartz R.J. SUMO-1 modification activated GATA4-dependent cardiogenic gene activity. J. Biol. Chem. 2004, 279:49091-49098.
48. Wang J., Zhang H., Iyer D., Feng X.H., Schwartz R.J. Regulation of cardiac specific nkx2.5 gene activity by small ubiquitin-like modifier. J. Biol. Chem. 2008, 283:23235-23243.
49. Wang J., Li A., Wang Z., Feng X., Olson E.N., Schwartz R.J. Myocardin sumoylation transactivates cardiogenic genes in pluripotent 10T1/2 fibroblasts. Mol. Cell. Biol. 2007, 27:622-632.
50. Yu L., Ji W., Zhang H., Renda M.J., He Y., Lin S., Cheng E.C., Chen H., Krause D.S., Min W. SENP1-mediated GATA1 deSUMOylation is critical for definitive erythropoiesis. J. Exp. Med. 2010, 207:1183-1195.